StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences cash

Cash and short-term investments held at the end of each period.

Korsana Biosciences's cash was $1.39M at Jun 30, 2026. For fiscal 2025 it was $3.24M, up 0.2% from the year before. The highest annual figure on record is $102.62M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.24M+0.2%
FY2024Dec 31, 2024$3.23M-57.3%
FY2023Dec 31, 2023$7.57M-43.4%
FY2022Dec 31, 2022$13.38M-75.2%
FY2021Dec 31, 2021$53.96M-7.3%
FY2020Dec 31, 2020$58.23M-43.3%
FY2019Dec 31, 2019$102.62M–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.39M-53.7%
Q1 FY2026Mar 31, 2026$2.82M-22.4%
Q4 FY2025Dec 31, 2025$3.24M+0.2%
Q3 FY2025Sep 30, 2025$4.57M+59.1%
Q2 FY2025Jun 30, 2025$3.01M-34.5%
Q1 FY2025Mar 31, 2025$3.64M-36.1%
Q4 FY2024Dec 31, 2024$3.23M-57.3%
Q3 FY2024Sep 30, 2024$2.87M-68.5%
Q2 FY2024Jun 30, 2024$4.59M-18.7%
Q1 FY2024Mar 31, 2024$5.70M-20.5%
Q4 FY2023Dec 31, 2023$7.57M-43.4%
Q3 FY2023Sep 30, 2023$9.11M-55.4%
Q2 FY2023Jun 30, 2023$5.64M-81.4%
Q1 FY2023Mar 31, 2023$7.17M-82.6%
Q4 FY2022Dec 31, 2022$13.38M-75.2%
Q3 FY2022Sep 30, 2022$20.41M-67.4%
Q2 FY2022Jun 30, 2022$30.32M-56.9%
Q1 FY2022Mar 31, 2022$41.13M-0.7%
Q4 FY2021Dec 31, 2021$53.96M-7.3%
Q3 FY2021Sep 30, 2021$62.50M-6.5%
Q2 FY2021Jun 30, 2021$70.39M+24.7%
Q1 FY2021Mar 31, 2021$41.43M-38.3%
Q4 FY2020Dec 31, 2020$58.23M-43.3%
Q3 FY2020Sep 30, 2020$66.84M-42.9%
Q2 FY2020Jun 30, 2020$56.46M-60.0%
Q1 FY2020Mar 31, 2020$67.10M–
Q4 FY2019Dec 31, 2019$102.62M–
Q3 FY2019Sep 30, 2019$117.03M–
Q2 FY2019Jun 30, 2019$141.03M–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–

More Korsana Biosciences figures

See a number that looks wrong?